STAAR Surgical director awarded 3,530 shares

STAAR Surgical director Lilian Yansheng Zhou acquired 3,530 shares of common stock on June 12, 2026 as a grant or award-type transaction.

Rhea-AI Filing Summary

STAAR Surgical director Lilian Yansheng Zhou acquired 3,530 shares of common stock on June 12, 2026 as a grant or award-type transaction. The weighted average price reported was $28.2904 per share, based on multiple trades between $28.215 and $28.35. Following this acquisition, Zhou directly holds 8,101 shares of STAAR Surgical common stock.

Insider Trade Summary

Grant/Award: 3,530 shares

Grant/Award 1 txn

Insider Zhou Lilian Yansheng

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,530	$28.2904	$100K

Holdings After Transaction: Common Stock — 8,101 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.215 to $28.35, inclusive.

Key Figures

Shares acquired: 3,530 shares Weighted average price: $28.2904 per share Price range: $28.215–$28.35 +1 more

4 metrics

Shares acquired 3,530 shares Common stock grant/award on June 12, 2026

Weighted average price $28.2904 per share Price for 3,530 acquired shares

Price range $28.215–$28.35 Range of multiple transactions underlying weighted average

Shares owned after 8,101 shares Total direct holdings following transaction

Key Terms

weighted average price, Grant, award, or other acquisition, Common Stock

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did STAAR Surgical (STAA) report for Lilian Yansheng Zhou?

STAAR Surgical reported that director Lilian Yansheng Zhou acquired 3,530 shares of common stock on June 12, 2026. The filing characterizes this as a grant, award, or other acquisition transaction, rather than an open-market buy or sale.

At what price were the 3,530 STAAR Surgical (STAA) shares acquired by the director?

The filing reports a weighted average price of $28.2904 per share for the 3,530 acquired shares. A footnote explains they were purchased in multiple transactions at prices ranging from $28.215 to $28.35, inclusive.

How many STAAR Surgical (STAA) shares does Lilian Yansheng Zhou hold after this Form 4 transaction?

After the June 12, 2026 acquisition, director Lilian Yansheng Zhou directly holds 8,101 shares of STAAR Surgical common stock. This total includes the 3,530 shares acquired in the reported grant, award, or other acquisition transaction.

What transaction code was used in the STAAR Surgical (STAA) Form 4 for this director award?

The transaction used code “A,” which the filing describes as a grant, award, or other acquisition of common stock. This indicates the shares were received as an award-type transaction rather than an open-market purchase or sale.

Does the STAAR Surgical (STAA) Form 4 show any stock option exercises or derivative trades?

No derivative transactions are listed in this Form 4. The derivativeSummary section is empty, and the only reported activity is a non-derivative acquisition of 3,530 shares of common stock by director Lilian Yansheng Zhou.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhou Lilian Yansheng

(Last) (First) (Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST CALIFORNIA 92630

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		3,530	A	$28.2904(1)	8,101	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.215 to $28.35, inclusive.

	/s/ Kathleen Determann as attorney-in-fact for Lilian Y. Zhou	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)